Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome

The aim of this study was to determine the acute and late toxicities associated with hypofractionated radiotherapy and to assess the impact of the addition of hormonal therapy to radiotherapy in high-risk prostate cancer patients on overall response and toxicity.
Dove Medical Press